Ad2/HIF-1α/VP16 gene transfer

· Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad2/HIF-1α/VP16 gene transfer, covering 2015-04-03 to 2015-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication [Phase 2]

See pricing